Law ❯ Litigation ❯ Class Action ❯ Securities Class Action

REGENXBIO, Inc.

REGENXBIO Investors Face April 14 Deadline to Seek Lead Role in RGX-111 Securities Suit

A looming deadline will set who leads the case.

REGENXBIO Investors Face April 14 Deadline to Seek Lead Role in Securities Suit